Prime Medicine, Inc.·4

Feb 23, 5:02 PM ET

Goldwasser Meredith 4

4 · Prime Medicine, Inc. · Filed Feb 23, 2024

Insider Transaction Report

Form 4
Period: 2024-02-21
Goldwasser Meredith
SVP, Strategy & Corporate Ops.
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-21+90,49890,498 total
    Exercise: $8.49Exp: 2034-02-21Common Stock (90,498 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wk-form4_1708725696.xmlPrimary

    FORM 4